NeuroMetrix, Inc. Names Walter Christensen as Senior Vice President of Global Sales

NeuroMetrix, Inc. (Nasdaq: NURO), a healthcare company transforming patient care through neurotechnology, announced today that it has named Walter Christensen to serve as its Senior Vice President of Global Sales, effective immediately.

Mr. Christensen brings over 30 years of experience in global, national and regional sales leadership for small and large multi-national medical device companies. In addition, Mr. Christensen has been involved in creating, expanding and reorganizing multi-national field sales network operations including direct and indirect sales staff.

Prior to joining NeuroMetrix, Mr. Christensen was the Senior Vice President of Global Sales at Stereotaxis, Inc. At Stereotaxis he created sales and business network strategies that established market share in Asia, Europe and the United States. Prior to Stereotaxis Mr. Christensen was Vice President, mid America zone at Philips Medical Systems. At Philips Medical Systems he created and expanded a successful U.S. sales operation that integrated the use of field sales personnel and a large dealer organization. Previously, Mr. Christensen served as General Manager at General Electric Medical Systems where he was responsible for the Nuclear/PET Division in North and South America. Mr. Christensen received his degree in business administration from Harrisburg Community College, Harrisburg, PA and his Radiology Technology Certification from Holy Spirit Hospital, Camp Hill, PA.

Shai N. Gozani, M.D., Ph.D, NeuroMetrix's President and CEO said, "We are excited to have Walt join the NeuroMetrix management team. He is an executive with both the intellect and extensive experience to positively impact and contribute to our business. I look forward to working closely with Walt as we continue developing NeuroMetrix into a premier neurotechnology focused healthcare company."

Walt Christensen commented, "NeuroMetrix represents a highly attractive opportunity and I am very excited to be joining Shai and the rest of the talented team at NeuroMetrix."

About NeuroMetrix

NeuroMetrix is a science-based healthcare company transforming patient care through neurotechnology. To date, our focus has been primarily on the assessment of neuropathies. Neuropathies affect the peripheral nerves and parts of the spine and are frequently caused by or associated with carpal tunnel syndrome, diabetes, sciatica, and other clinical disorders. We market systems for the performance of nerve conduction studies and needle electromyography procedures. Our product pipeline includes a system designed to deliver pharmacologic agents such as anesthetics and corticosteroids in close proximity to nerves for regional anesthesia, pain control and the treatment of focal neuropathies. We are also developing neurostimulation-based devices that promote nerve fiber regeneration in acute peripheral nerve and spinal cord injuries. For more information, visit http://www.neurometrix.com.